CBS 2019
CBSMD教育中心
中 文

Scientific Library

Abstract

Recommended Article

Extracellular Vesicles From Epicardial Fat Facilitate Atrial Fibrillation Optical Coherence Tomography Guided Percutaneous Coronary Intervention With Nobori Stent Implantation in Patients With Non-ST-Segment-Elevation Myocardial Infarction (OCTACS) Trial: Difference in Strut Coverage and Dynamic Malapposition Patterns at 6 Months Twelve or 30 months of dual antiplatelet therapy after drug-eluting stents Evolution of antithrombotic therapy in patients undergoing percutaneous coronary intervention: a 40-year journey The optimal duration of dual antiplatelet therapy after coronary stent implantation: to go too far is as bad as to fall short Antiplatelet therapy in patients with myocardial infarction without obstructive coronary artery disease A randomized comparison of Coronary Stents according to Short or Prolonged durations of Dual Antiplatelet Therapy in patients with Acute Coronary Syndromes: a pre-specified analysis of the SMART-DATE trial Instantaneous Wave-free Ratio versus Fractional Flow Reserve to Guide PCI

Original Research2020 Jun 7;128:110336.

JOURNAL:Biomed Pharmacother. Article Link

Comparison of the Preventive Efficacy of Rosuvastatin Versus Atorvastatin in Post-Contrast Acute Kidney Injury in Patients With ST-segment Elevation Myocardial Infarction Undergoing Percutaneous Coronary Intervention

YN Dai, JL Huang, DQ Yu et al. Keywords: atorvastatin; rosuvastatin; STEMI; PCI; post-contrast acute kidney injury

Full Text PDF